Sprouty2, a Mouse Deafness Gene, Regulates Cell Fate Decisions in the Auditory Sensory Epithelium by Antagonizing FGF Signaling  by Shim, Katherine et al.
Developmental Cell, Vol. 8, 553–564, April, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.devcel.2005.02.009
Sprouty2, a Mouse Deafness Gene, Regulates
Cell Fate Decisions in the Auditory Sensory
Epithelium by Antagonizing FGF Signaling
Katherine Shim,1 George Minowada,1,3
Donald E. Coling,2,4 and Gail R. Martin1,*
1Department of Anatomy and
Program in Developmental Biology
School of Medicine
University of California, San Francisco
San Francisco, California 94143
2Laboratory of Molecular Otology
Saul and Ida Epstein Laboratories
Department of Otolaryngology
University of California, San Francisco
San Francisco, California 94143
Summary
The auditory sensory epithelium (organ of Corti),
where sound waves are converted to electrical sig-
nals, comprises a highly ordered array of sensory re-
ceptor (hair) cells and nonsensory supporting cells.
Here, we report that Sprouty2, which encodes a nega-
tive regulator of signaling via receptor tyrosine ki-
nases, is required for normal hearing in mice, and that
lack of SPRY2 results in dramatic perturbations in or-
gan of Corti cytoarchitecture: instead of two pillar
cells, there are three, resulting in the formation of an
ectopic tunnel of Corti. We demonstrate that these ef-
fects are due to a postnatal cell fate transformation of
a Deiters’ cell into a pillar cell. Both this cell fate
change and hearing loss can be partially rescued by
reducing Fgf8 gene dosage in Spry2 null mutant mice.
Our results provide evidence that antagonism of FGF
signaling by SPRY2 is essential for establishing the
cytoarchitecture of the organ of Corti and for hearing.
Introduction
One of the most striking examples of cellular patterning
in vertebrates is found in the auditory sensory epithe-
lium or organ of Corti (oC). The oC is a specialized re-
gion of the inner ear (cochlear) epithelium composed of
a highly ordered array of sensory (hair) and nonsensory
(supporting) cell types (see Figure 3M; reviewed in Kier-
nan et al., 2002). The two types of mechanosensory hair
cells in the oC, inner and outer hair cells (IHCs and
OHCs), are arranged such that a single row of IHCs and
three evenly spaced rows of OHCs run along the length
of the snail-like cochlea from base to apex. The sup-
porting cells of the oC are also organized in a precise
pattern. For example, there are two rows of pillar cells
(inner and outer) separating the IHC row from the OHC*Correspondence: gmartin@itsa.ucsf.edu
3 Present address: Department of Medicine, Division of Pulmonary
and Critical Care Medicine, Case Western Reserve University,
School of Medicine, University Hospitals of Cleveland, Cleveland,
Ohio 44106
4 Present address: Center for Hearing and Deafness, 137F Cary Hall
(South Campus), The State University of New York at Buffalo, Buf-
falo, New York 14214rows. In a mature oC, inner and outer pillar cells form a
distinctive space, the tunnel of Corti, that appears as
an open triangle in cross-section (see Figure 4I). Adja-
cent to the pillar cells, Deiters’ cells are also organized
in an evenly spaced array such that a Deiters’ cell is
invariably found underlying each OHC. Recent work
has demonstrated roles for two signaling pathways in
patterning the oC: Notch signaling plays a role in hair
cell specification (reviewed in Kelley, 2003; Kiernan et
al., 2002), and fibroblast growth factor (FGF) signaling
is required to generate hair cell progenitor pools (via
FGF receptor 1 [Fgfr1]) (Pirvola et al., 2002) and for pil-
lar cell specification/differentiation (via FGF receptor 3
[Fgfr3]) (Colvin et al., 1996). However, little else is
known about the molecular mechanisms whereby the
exquisite cytoarchitecture of the oC is achieved dur-
ing development.
The oC plays a pivotal role in hearing: it converts the
mechanical energy resulting from complex sound pres-
sure waves into electrical signals that are transmitted
to the brain. Given the central role of the hair cell as the
mechanosensory receptor, it is not surprising that there
are many mutations that cause hearing deficits due to
loss or malfunction of hair cells (reviewed in Steel and
Kros, 2001). However, one might predict that hearing
deficits would also be caused by perturbations in the
cytoarchitecture of the oC due to effects on supporting
cells. To date, the only mutant mice in which hearing
loss has been attributed to abnormalities in the cellular
pattern of the supporting cells are Fgfr3−/− mice (Colvin
et al., 1996). Further genetic analysis is needed to de-
termine how the cytoarchitecture of the supporting
cells of the oC influences hearing function.
Here, we have explored the role in oC morphogenesis
and hearing of Sprouty2 (Spry2), a member of the
Sprouty family of negative feedback regulators of sig-
naling via receptor tyrosine kinases (RTKs), including
FGF receptors. The first member of this gene family,
sprouty (spry), was identified in Drosophila, where it
was shown to antagonize RTK signaling during tracheal
branching (Hacohen et al., 1998), and other develop-
mental processes (Casci et al., 1999; Kramer et al.,
1999; Reich et al., 1999). In the mouse, four Sprouty
genes (Spry1–Spry4) comprise a family of membrane-
associated intracellular proteins that share a cysteine-
rich carboxyl terminal region that is highly conserved
across species (de Maximy et al., 1999; Minowada et
al., 1999). Overexpression of Sprouty genes in verte-
brates perturbs a number of developmental processes,
including limb (Minowada et al., 1999), lung (Mailleux et
al., 2001; Perl et al., 2003), and kidney development
(Chi et al., 2004), as well as convergent extension
movements during Xenopus gastrulation (Nutt et al.,
2001). Like their Drosophila homologs, vertebrate
Sprouty family members have been shown to act intra-
cellularly to negatively regulate FGF and other RTK sig-
naling through diverse biochemical mechanisms, pri-
marily via effects on the MAPK pathway (reviewed in
Dikic and Giordano, 2003; Guy et al., 2003; Kim and
Bar-Sagi, 2004). Here, we describe the production of
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tSpry2. We show that Spry2 plays a key role in the de-
termination of supporting cell fate in the oC, and that l
HSpry2 null mice are severely hearing impaired.
S
SResults
Generation of Mice Carrying Spry2 Null S
Sand Conditional Null Alleles
To explore Spry2 function in mice, we used the same p
sstrategy we previously employed to generate an Fgf8
mutant allelic series (Meyers et al., 1998) to produce s
canimals carrying the Spry2 mutant alleles illustrated
in Figure 1. Animals homozygous for either the s
tSpry2neo-flox or Spry2flox allele were viable and fertile
and displayed no obvious defects. When crossed in- S
tterse, animals heterozygous for Spry2ORF, a null allele
in which the entire Spry2 open reading frame is deleted, 2
oproduced Spry2ORF/ORF progeny at Mendelian fre-
quency at birth (n = 11/42; 26%). By weaning (postnatal d
aday [P] 21–28), almost half of the Spry2ORF/ORF mice
had died, and many of the remaining homozygotes (
wwere significantly small than normal. Preliminary analy-Figure 1. Production of a Spry2 Mutant Al-
lelic Series
(A) Schematic representation of the Spry2
wild-type allele, targeting vector, and
Spry2neo-flox allele produced by gene replace-
ment in ES cells. A horizontal line and blue
box represent Spry2 genomic DNA and the
Spry2 open reading frame (ORF; contained
within a single exon), respectively. Positive
and negative selection during targeting were
provided by a neomycin-resistance (NEO)
expression cassette (tan box) and a diphthe-
ria toxin A (DTA) expression cassette (black
box), respectively, each under the control of
a Pgk1 promoter. Open and filled triangles
represent frt and loxP sites, the recognition
sequences for Flp and Cre recombinases,
respectively. The two pairs of dotted parallel
lines demarcate the regions in which homol-
ogous recombination occurred. The posi-
tions of restriction enzyme sites used for
generation of the targeting vector or for
genotyping are indicated: B, BamHI; E,
EcoRI; H, HindIII; S, SacII. The positions of
the probes and primers (P1–P4) used for
genotyping the various alleles are indicated.
Mice heterozygous for Spry2neo-flox were pro-
duced as described and were mated to flp
transgenic mice (Rodriguez et al., 2000) to
generate animals carrying the Spry2flox con-
ditional null allele. Mice heterozygous for
Spry2flox were mated to β-Actin-cre trans-
genic mice (Lewandoski et al., 2000) to gen-
erate animals carrying the Spry2ORF null
allele.
(B) Identification of ES cells and mice carry-
ing Spry2 mutant alleles. Correctly targeted
ES cells carrying Spry2neo-flox were identified
by Southern blotting by using the restriction
enzymes and probes indicated. Mice hetero-
zygous or homozygous for Spry2flox or
Spry2ORF were identified by a PCR assay by
using the primers indicated.is of the vital organs pointed to abnormalities in gas-
rointestinal tract function as a possible cause of this
ethality (P.-F. Lu, G.M., and G.R.M., unpublished data).
ere, we report on a separate phenotype observed in
pry2ORF/ORF homozygotes, hereafter referred to as
pry2−/− mice or Spry2 null mutants.
pry2 Null Mutants Are Severely Hearing Impaired
pry2−/− mice that survived past weaning did not ap-
ear to respond to loud noises. Auditory brainstem re-
ponse (ABR) tests revealed that at P21, Spry2−/− mice
uffered from intermediate to severe hearing loss, with
lick-evoked ABR thresholds averaging 76 decibels
ound pressure level (dB SPL), 60 dB higher than in
heir Spry2+/+ littermates (average threshold = 16 dB
PL) and 53 dB higher than in Spry2+/− littermate con-
rols (average threshold = 23 dB SPL) (Figures 2A and
B; see Figure S1A in the Supplemental Data available
nline). The initiation of hearing function was not simply
elayed, because ABR tests showed that Spry2−/− mice
t 7, 10, or 19 weeks were also hearing impaired
average threshold = 79 dB SPL). The absence of a
ave i response in the ABR tests (Figures 2A and 2C)
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(A and B) ABR waveform patterns and thresholds for 3-week-old
Spry2 null homozygotes (−/−), heterozygotes (+/−), and wild-type
(+/+) littermates. Patterns, induced by click stimuli ranging from 10
to 70 decibel sound pressure levels (dB SPL) for all animals, and
to 90 dB SPL for −/− animals (not shown), represent averaged
waveforms for 12 ears (6 mice) for each genotype. Seven charac-
teristic response peaks (waves i–vii) are indicated. The error bars
indicate standard deviations.
(C) ABR wave i peak amplitudes, as measured in (B), are plotted as
a function of stimulus intensity for the different genotypes. Ampli-
tude and slope for the wave i responses in Spry2−/− mutants are 0.
Neither wave i amplitude response nor slope differ significantly in
heterozygotes versus their wild-type littermates.indicates the lack of activity of the bipolar neurons that
directly innervate the cochlea (Møller and Jannetta,
1985). This suggests that hearing loss was due to a
defect either in the nerve (spiral ganglion) itself, or at
an earlier step in hearing.The Middle Ear Ossicles, Inner Ear Labyrinth,
and Spiral Ganglion Appear Normal
in Spry2 Null Mutants
During hearing, sound pressure waves cause vibration
of the tympanic membrane, leading to the transmission
of vibrational energy through the ossicles of the middle
ear to the oC of the inner ear. In the oC, this vibrational
energy is converted into electrical impulses that are
transmitted by the spiral ganglion to the brain. To ex-
plore the basis of the hearing defects in the Spry2 null
mutants, we examined the middle ear, inner ear, and
spiral ganglion. There were no gross defects in the
shape of the ossicles (malleus, incus, stapes) or in the
articulation of the malleus to incus, incus to stapes, or
stapes to the oval window of the inner ear in Spry2−/−
mice (Figures 3A and 3B, and data not shown). This
suggests that their hearing defect is unlikely to be due
to a failure in sound pressure conduction.
We next examined the inner ear labyrinth, which be-
gins developing at wE9.5 from an epithelial sac and
undergoes a complex morphogenesis to achieve its
nearly mature structure by wE15.5 (Morsli et al., 1998).
At that stage, it comprises the cochlea and the vesti-
bule, which is required for balance. We found no abnor-
malities in the gross structure of the inner ear labyrinth
of E15.5 Spry2 null mutants by using the paint-filling
technique (Martin and Swanson, 1993) to visualize its
lumen (Figures 3C and 3D). The cochlea appeared to
have completed the appropriate number of turns, and
the semicircular canals, utricle, and saccule of the ves-
tibule were properly positioned. Consistent with the lat-
ter observation, vestibular function appeared unaf-
fected in Spry2−/− adults as measured by multiple
criteria (Bergstrom et al., 1998): (1) absence of hyperac-
tivity, head-tossing, or circling behavior; (2) proper dor-
sal flexion and extension of forelimbs upon tail hanging;
(3) ability to orient when inverted in a conical tube; and
(4) ability to swim (data not shown).
In the cochlea, no gross abnormalities were detected
by histological analysis at E18.5 and P21 in structures
essential for normal hearing, including the stria vascu-
laris, tectorial membrane, and basilar membrane (data
not shown). Furthermore, although defects in the ste-
reocilia of the hair cells are often the cause of severe
hearing deficits, we found no obvious abnormalities in
the hair bundles of the IHCs and OHCs of Spry2 null
mutants by scanning electron microscopy (Figures 3E
and 3F, and data not shown).
In addition, no obvious abnormalities were detected
in the neurons that directly innervate the cochlea by
either neurofilament staining at P0 or by histological
analysis at P15 and P21 (Figures 3G, G#, H, and H#, and
data not shown).
Extra Outer Hair Cells and Supporting Cells Are
Present in the Spry2−/− Organ of Corti
We next looked more closely at the cytoarchitecture of
the oC. As in normal mice (see Figure 3M), Spry2 null
mutants contained a single longitudinal row of IHCs,
as determined by examination of dissected cochlea
stained in whole mount with rhodamine phalloidin,
which labels the actin-rich hair cells intensely (Figures
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(A and B) Middle ear ossicles (stapes [St], incus [In], malleus [Ma]) of P8 control and Spry2−/− mice stained with Alcian blue and Alizarin red.
(C and D) Paint-filled inner ear labyrinths from E15.5 control and Spry2−/− embryos. Dorsal views of the cochlea (insets) show that it has
completed one and a half turns in both control and Spry2−/− embryos. Location of the cochlea (Co), vestibule (Ve), and site of paint injection
(arrowhead) are indicated.
(E and F) Scanning electron micrographs at P21 showing the stereocilia on the apical surface of individual outer hair cells (OHCs).
(G and H) Spiral ganglion from P0 control and Spry2−/− mice stained for neurofilament (NF) protein.
(G# and H#) Higher magnification views in which the neuronal dendrites from the inner hair cell (nIHC) and OHC (nOHC) rows are indicated.
The region shown in (H#) appears to contain four OHC rows (see below), rather than the normal three rows shown in (G#).
(I and J) Surface views of the oC at P0, stained for actin. The region of the Spry2−/− cochlea shown in (J) has four rows of OHCs instead of
the three found in the control and elsewhere in the Spry2 null oC. The pillar cell (PC), inner hair cell (IHC), and OHC rows are indicated.
(K–L#) (K and L) Cross-sections through the oC at P5 stained for p75, which labels the inner PC, Deiters’ cells (DC), Hensen’s cells (HC), and
Claudius’ cells (CC), and counterstained with a green nuclear dye. (K# and L#) The same photomicrographs as in (K) and (L), showing only
the p75 staining. The Deiters’ cells are readily identified by a distinctive Y-shaped staining pattern: (L and L#) The Spry2 null mutant has four
Deiters’ cells, supporting the four OHCs, and extra Claudius’ cells.
(M) Schematic diagram showing the normal morphology and cell types comprising the organ of Corti (oC) at P1.3I and 3J). However, instead of the normal three longitu-
tdinal rows of OHCs, we detected four. Over a 3 mm
length of cochlea starting from the base (representing w
iw55% of its total length), we counted an average of
142 fourth row OHCs in Spry2−/− (n = 3), 6 in Spry2+/− u
t(n = 3), and 0 (n = 2) or 1 (n = 1) in Spry2+/+ mice (see
Table S1). The extra OHCs were found in patches that d
salternated with regions containing the normal three
rows. These patches appeared more frequently and 3
twere longer toward the apex.In cross-sections through the oC at P0–P5, we found
hat in every transverse section in which a fourth OHC
as observed in Spry2 null mutants, an extra support-
ng cell was also present underlying the extra OHC (Fig-
res 3K and 3L). The extra supporting cell was iden-
ified as a Deiters’ cell based on the presence of a
istinctive Y-shaped structure readily detected by
taining for p75NGFR (von Bartheld et al., 1991) (Figures
K# and 3L#) or for tubulin (Figures 4A and 4B). In addi-
ion, we also observed multiple regions with more sup-
SPRY2 Function in Inner Ear Development
557Figure 4. An Extra, Third Pillar Cell Forms in Spry2 Null Mutants
during Postnatal Differentiation of the Organ of Corti
(A–B#) Cross-sections through oC at P3 stained for tubulin (green)
and a red nuclear dye. The Spry2 null mutant has two normal pillar
cells and four Deiters’ cells.
(C and D) Similarly stained cross-sections through oC at P10. At
this stage, the Spry2 null mutant has a third, extra pillar cell with its
nucleus (filled arrowhead) near the basilar membrane, and a thick
tubulin-stained process extending to the lumenal surface (open ar-
rowhead). The adjacent Deiters’ cells extend thinner tubulin-
stained processes to the lumenal surface. The third pillar cell ap-
pears at the expense of the Deiters’ cell nearest to the outer pillar
cell, leaving three remaining Deiters’ cells and stranding an OHC
without a supporting cell (arrow).
(E–H) Cross-sections through oC at the ages indicated, stained for
S100 (red) and counterstained with a green nuclear dye. An extra
pillar cell is present in the Spry2 null mutant (arrowheads), irrespec-
tive of whether it has (F) four or (H) three OHCs, leaving three or
two remaining Deiters’ cells, respectively. In each case, an OHC isand 4F), and in regions of the cochlea where the normal
stranded without a supporting Deiters’ cell (arrow).
(I and J) Schematic diagrams of mature oC in wild-type and Spry2−/−
mice. The constituent cell types, the tunnel of Corti formed by the
pillar cells, and the nerves of the spiral ganglion (n) are indicated.
Note that in the Spry2 null mutant there is a second tunnel of Corti-
like space between the outer and ectopic pillar cells, in which the
OHC is stranded.porting Claudius’ cells, which are also marked by
p75NGFR (Figures 3K, 3K#, 3L, and 3L#, and data not
shown).
Spry2 Null Mutants Develop an Extra Pillar Cell
between P5 and P10
At P0–P5, when we observed increased OHC, Deiters’,
and Claudius’ cell numbers in Spry2−/− mice, pillar cell
number appeared normal. At those stages, p75NGFR is
detected in only one of the two normal pillar cells, the
inner pillar cell. In Spry2 null mutants and littermate
controls alike, we always saw a single p75NGFR-positive
inner pillar cell, and between it and the nearby p75NGFR-
positive Deiters’ cell, we always saw a single nucleus,
presumably of the outer pillar cell (n = 6 Spry2−/− mice;
n = 7 Spry2−/+ or Spry2+/+controls; Figures 3K and 3L).
Moreover, using an anti-tubulin antibody, we detected
only the normal two pillar cells in both Spry2 null mu-
tants and controls at P3 (Figures 4A# and 4B#).
At P10, pillar cell differentiation is nearly complete:
the nuclei of the inner and outer pillar cells have moved
apart basally, and the cells have changed shape so that
they touch one another only at their extreme apical and
basal ends, forming the space that constitutes the tun-
nel of Corti (see Figure 4I). When stained with an anti-
body against tubulin, the apical process of the dif-
ferentiated pillar cells has a distinctive pattern of
staining, showing numerous microtubule bundles (Fig-
ure 4C). Strikingly, at this stage in Spry2 null mutants,
we found that in addition to the two normal pillar cells
there appeared to be an ectopic, third pillar cell, which
like the normal inner and outer pillar cells, extended a
heavily tubulin-labeled process from the basilar mem-
brane to the lumenal surface (open arrowhead in Figure
4D). This third pillar cell was also clearly seen in sec-
tions stained for nuclei and S100, a protein that is en-
riched in pillar cell and Deiters’ cell bodies (Pack and
Slepecky, 1995) (Figures 4E and 4F; Figure S2). The
presence of this cell created an aberrant, second tunnel
of Corti-like space between it and the normal outer pil-
lar cell. This second tunnel always contained a single
OHC that was stranded without a supporting Deiters’
cell.
Importantly, in contrast to the patchy increase in
OHC/Deiters’ cell (OHC/DC) numbers, the third pillar
cell was observed in virtually every transverse row of
each Spry2−/− oC examined (n = 6 Spry2−/− mice; n = 5
Spry2+/+ controls); thus, in regions of the cochlea where
four OHCs were present, we always observed a third
pillar cell with three remaining Deiters’ cells (Figures 4D
Developmental Cell
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Figure 5. Spry2, Spry1, Fgfr3, and Fgf8 Expression during Organ of
lCorti Development
pIn situ hybridization analysis of the genes at the developmental
stages indicated in wild-type cochlea sectioned to visualize the oC.
S(A and B) Brackets indicate the domains of Spry2 and Spry1 ex-
pression in the presumptive oC at E14.5. P
(C) Cells expressing or not expressing Spry2 are labeled in black p
or gray lettering, respectively. e
(D–H) Cells expressing the genes indicated are labeled. (E and G)
aNote that in Deiters’ cells at P5, Spry2 and Fgfr3 RNAs are detected
sprimarily in the phalangeal process of each cell, which extends to
tthe right of the overlying OHC.
(I) Schematic diagram of the oC at P5 in which the domains of e
Spry2, Spry1, Fgfr3, and Fgf8 are illustrated. i
a
Kthree OHCs were present, we always observed a third
pillar cell with two remaining Deiters’ cells (Figure 4H). a
sThus, it appears that sometime between P5 and P10
the Deiters’ cell closest to the outer pillar cell trans- s
eforms into a third pillar cell in Spry2 null mutants, creat-
ing a second tunnel of Corti-like space and dramatically t
sdisrupting the cytoarchitecture of the oC. This disrup-
tion persists into adulthood and was observed in Spry2 d
emutants that measured as deaf by the ABR test at P21
(n = 5 Spry2−/− mice; n = 5 Spry2+/+ controls; Figures FG–4J). Very occasionally, two extra pillar cells were
bserved (data not shown).
pry2 Expression in the Organ of Corti
prouty genes encode proteins thought to function in-
racellularly. Thus, to explore which cells might be di-
ectly affected by loss of Spry2 function, we performed
n in situ hybridization analysis of Spry2 expression in
hole mount and in cryosections taken along the
ength of the wild-type cochlea. At E11.5, in the co-
hlear portion of the otocyst, Spry2 RNA was detected
n a broad but discrete medial domain of the inner ear
pithelium (data not shown). In the cochlea at E14.5,
efore different cell types have become morphologi-
ally distinct, Spry2 RNA was detected in most or all of
he presumptive oC region (Figure 5A). At E16.5 and
17.5, when the constituent cell types of the oC could
e clearly identified, Spry2 RNA was detected in pillar
ells, Deiters’ cells, Claudius’ cells, and Hensen’s cells,
nother supporting cell type. Reduced or no Spry2 ex-
ression was observed in IHCs and OHCs at this stage
Figure 5C and data not shown). By P5, just before the
illar cell phenotype becomes evident in Spry2 null mu-
ants, Spry2 RNA in wild-type animals was clearly de-
ected in Deiters’ cells, but appeared to be consider-
bly less abundant in other cell types (Figures 5E and
I, and data not shown). Spry2 expression continued in
eiters’ cells until P7, the latest stage assayed (data
ot shown). Thus, Spry2 is initially expressed in a broad
omain in the oC prior to cytological differentiation of
ts constituent cell types, and by the end of oC matura-
ion at P5–P7, it appears to be enriched in Deiters’ cells.
We found that at least one other member of the
prouty gene family, Spry1, was coexpressed with
pry2 during oC development. At E14.5, Spry1 RNA
as detected in a thin stripe of cells, w2 cells wide, in
he presumptive oC region, and in a small region of the
ochlear epithelium outside of the oC (Figure 5B). At
16.5, after cell differentiation had commenced, and as
ate as P5, Spry1 RNA was localized to just the two
illar cells (Figures 5D, 5F, and 5I).
pry2 Genetically Antagonizes FGF8 Signaling
revious studies have shown that at E16.5, Fgf8 is ex-
ressed in the IHCs and its putative receptor, Fgfr3, is
xpressed in the adjacent pillar cells as well as in OHCs
nd Deiters’ cells (Pirvola et al., 2002). We detected a
imilar pattern in wild-type animals at P5, just before
he pillar cell phenotype is observed in Spry2 mutants,
xcept that Fgfr3 no longer appeared to be expressed
n OHCs (Figures 5G–5I). Since both Fgf8 (U. Pirvola
nd A. Neubuser; B. Jacques, M. Lewandoski, and M.
elley, personal communication) and Fgfr3 (Colvin et
l., 1996) are required for pillar cell differentiation, this
uggests a model in which FGF8, produced in the IHCs,
timulates the differentiation of pillar cells. One hypoth-
sis that could explain our findings is that Spry2 func-
ion is required to limit the range of the FGF8 signal,
o that only the two cells nearest the source of FGF8
ifferentiate as pillar cells. When SPRY2 is absent, the
ffective range of FGF8 is expanded so that now an
gfr3-expressing Deiters’ cell takes on a pillar cell fate
SPRY2 Function in Inner Ear Development
559(see Figure 7B). The consequent disruption of oC cyto-
architecture might be the cause of the observed hear-
ing deficit.
One prediction of this hypothesis is that reducing the
amount of FGF8 should prevent both the excess pillar
cell phenotype (see Figure 7B) and the hearing impair-
ment observed in Spry2 null mutants. To test this pre-
diction, we produced Spry2 null mutants in which Fgf8
gene dosage was reduced, tested their hearing, and
then examined the oC (Figures 6A–6E). In Spry2 null
mutants with wild-type Fgf8 gene dosage, virtually ev-
ery transverse section observed had an extra pillar cell
by P21 (average of 39 third pillar cells over a 300 m
length of cochlea; n = 3; Figure 6B), whereas in their
Spry2−/−;Fgf8+/− littermates, we saw extended regions
in which there were the normal two pillar cells (average
of 20 third pillar cells/300 m; n = 5; Figures 6C–6E),
representing an w50% reduction in the incidence of an
aberrant third pillar cell. In Spry2+/+;Fgf8+/− littermate
controls, we never observed a third pillar cell (Figure
6A; see Table S2). The significant rescue of the pillar
cell defect in Spry2−/− mice with reduced Fgf8 gene
dosage suggests that the normal function of SPRY2 is
to antagonize FGF8 signaling in Deiters’ cells. In con-
trast, there did not appear to be any rescue of the extra
OHC/DC phenotype in Spry2−/−;Fgf8+/− mice (data not
shown).Figure 6. Pillar Cell Development and Hear-
ing Are Partially Rescued in Spry2−/− Animals
by Reducing Fgf8 Gene Dosage
(A–E) Cross-sections through oC at P21
stained for S100 and counterstained with a
green nuclear dye. The filled arrowhead in
(B) and (E) points to the nucleus of the extra
pillar cell, and the open arrowhead points to
the apical process of the extra pillar cell. (A)
Normal oC morphology in a Spry2+/+;Fgf8+/−
animal. (B) Typical section of an Spry2−/−;
Fgf8+/+ oC showing an extra pillar cell. (C–E)
Examples of the variation in phenotype ob-
served within an individual Spry2−/−;Fgf8+/−
oC. In (C) and (D), there are three or four
rows of OHCs/Deiters’ cells, respectively,
but no extra pillar cell (asterisk). In (E), an
extra pillar cell is still observed.
(F) ABR waveform patterns and thresholds
for 3-week-old mice of the genotypes indi-
cated are shown as described in the legend
to Figure 2. Each ear was individually mea-
sured in n = 6 Spry2+/+;Fgf8+/−, n = 4 Spry2−/−;
Fgf8+/+, and n = 9 Spry2−/−;Fgf8+/− mice.The ABR hearing tests conducted on these animals
prior to examination of oC cytoarchitecture showed
that, as expected, Spry2+/+;Fgf8+/− P21 controls had
normal hearing (average ABR threshold = 11 dB SPL).
Spry2−/−;Fgf8+/+ littermates had the expected severe
hearing loss, 55 dB higher than the Spry2+/+;Fgf8+/−
controls (average ABR threshold = 66 dB SPL). How-
ever, Spry2−/−;Fgf8+/− littermates showed partial rescue
of hearing function with average ABR thresholds 31 dB
higher than the Spry2+/+;Fgf8+/− controls (average ABR
threshold = 42 dB SPL; Figure 6F). These results re-
flected a range of rescue: some mice showed substan-
tial improvement, with ABR thresholds as low as 24 dB
SPL; others showed intermediate rescue of hearing
function, with ABR thresholds at about 39–44 dB SPL;
and some mice showed little or no rescue of hearing
function (see Figure S1B). However, the differences in
mean ABR threshold values measured in Spry2−/−;
Fgf8+/+ versus Spry2−/−;Fgf8+/− mice were statistically
significant by two independent tests (p = 0.001, Stu-
dent’s two-tailed t test; p = 0.0021, Mann-Whitney test).
These data demonstrate a positive correlation between
rescue of the extra pillar cell phenotype and improve-
ment in auditory function, consistent with the hypothe-
sis that disruption of the cytoarchitecture of the organ
of Corti caused by loss of Spry2 function is responsible
for the hearing deficit.
Developmental Cell
560Discussion t
l
mThe ability to hear depends upon normal form and func-
dtion of the organ of Corti. We report here that Spry2−/−
mmice suffer from severe congenital hearing loss (Figure
c2), and we have identified two aspects of oC develop-
ament that are dependent on Spry2 function (Figure 7A).
First, Spry2 is required to prevent the formation of ex-
ocess OHCs, their underlying Deiters’ cells, and the
gnearby Claudius’ cells. Second, Spry2 is required to
aprevent a Deiters’ cell from undergoing a cell fate con-
1version into a pillar cell in the early postnatal period.
(The effect of loss of Spry2 function on pillar cell number
Sand hearing can be at least partially rescued by reduc-
aing Fgf8 gene dosage, indicating that Spry2 normally
cfunctions to prevent this cell fate conversion by antago-
7nizing FGF8 signaling.
p
u
SPRY2 Prevents the Formation of Excess Outer m
Hair Cells and Supporting Cells I
In many cross-sections of Spry2 mutant cochlea, in ad- m
dition to the normal three OHCs, each with an underly- t
ing Deiters’ cell, we observed a fourth OHC/DC pair as p
well as more Claudius’ cells than normal (Figures 3I– n
3L#). No effects on these cells were detected other than s
Dthis regional increase in number, as judged by actin,Figure 7. Model of Spry2 Function during Organ of Corti Development
(A) Schematic diagram of the oC at the developmental stages indicated, showing stages at which Spry2 function is required.
(B) Diagrams of the oC at P5 (top row) and P10 (bottom row) for the genotypes indicated. At P5, the domains of Fgf8 expression in the IHCs
and Spry2 expression in the Deiters’ cells are shaded orange and blue, respectively. Pillar cells are highlighted in purple at both P5 and P10.
According to our model, in the wild-type oC the effective range of FGF8 signaling (triangle) is limited by intracellular Spry2 activity in the Dei-
ters’ cells. In the Spry2−/− oC, SPRY2-negative regulation of FGF8 signaling is missing, resulting in a larger effective range of the FGF8 signal.
This results in the formation of an extra pillar cell by P10. In the Spry2−/−;FGF8+/− oC, although SPRY2-mediated negative regulation is absent,
less FGF8 ligand is produced by the IHCs (indicated by stippling), and therefore the effective range of FGF8 signaling is decreased. Thus,
only the normal two pillar cells are present at P10.ubulin, and p75 staining and by morphology in histo-
ogical sections. Furthermore, the extra OHCs develop
orphologically normal stereocilia. Together, these
ata indicate that Spry2 is required to prevent the for-
ation of excess OHCs, Deiters’ cells, and Claudius’
ells, but does not function to regulate their differenti-
tion.
During normal development, cells in the prospective
C region undergo a round of terminal mitosis that pro-
resses in a wave starting at the apex of the cochlea
t E11.5 and finishing at the base by E15.5 (Ruben,
967), after which cellular differentiation commences
Lim and Anniko, 1985; Sher, 1971). It seems likely that
pry2 function plays a role sometime between E11.5
nd E15.5 in determining the numbers of OHC, Deiters’
ell, and Claudius’ cell progenitors that form (Figure
A). One or a combination of mechanisms could ex-
lain how Spry2 functions in this context, including reg-
lation of the time at which the progenitor cells exit
itosis. However, since there are normal numbers of
HCs and pillar cells in newborn Spry2 mutants, there
ust be some mechanism whereby loss of Spry2 func-
ion affects only OHC, Deiters’ cell, and Claudius’ cell
rogenitors. In addition, at birth, OHC and Deiters’ cell
umbers always match in the Spry2 mutants. Thus, it
eems that the mechanism(s) that ensure proper OHC/
C pairing is still intact in the absence of SPRY2.
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on a Pillar Cell Fate
Our data show that in the absence of Spry2 function,
sometime between P5 and P10 a Deiters’ cell, which
cups an OHC and sends a thin process to the lumenal
surface, transforms into a pillar cell, which extends a
thick process to the lumenal surface. Importantly, this
cell fate transformation occurs in every row of the oC,
irrespective of whether or not a fourth OHC/DC pair
formed as an earlier consequence of loss of Spry2
function. Thus, the effect of loss of Spry2 function on
pillar cell formation is independent of its effect on OHC/
DC numbers. The finding that a Deiters’ cell can trans-
form into a pillar cell after P5 indicates that once speci-
fied during embryogenesis, Deiters’ cells are not com-
mitted to a Deiters’ cell fate. Rather, cell fates remain
plastic and cell fate information must be continuously
provided over the course of oC maturation. Consistent
with this idea, FGFR3 signaling is continuously required
for pillar cell differentiation in cochlear explant cultures
(Mueller et al., 2002). Our conclusion that Spry2 is re-
quired to prevent a cell fate transformation in the oC is
consistent with observations in Drosophila that sprouty
functions as a regulator of cell fate in multiple develop-
mental settings (Casci et al., 1999; Hacohen et al., 1998;
Kramer et al., 1999; Reich et al., 1999). Thus, it appears
that this function of sprouty has been conserved
through evolution.
We detected expression of another Sprouty family
member, Spry1, in the developing oC. However, in con-
trast to Spry2, which is initially broadly expressed in
oC progenitor cells and then becomes enriched in the
Deiters’ cells by P5, Spry1 appears to mark only pillar
cells from very early stages (Figure 5). Preliminary data
suggest that Spry1 null mice (Basson et al., 2005) are
not hearing impaired (not shown), but analysis of
double mutants will be required to determine if Spry1
and Spry2 are functionally redundant in pillar cells,
where they are coexpressed.
Spry2 Is a Negative Regulator of FGF Signaling
in the Organ of Corti
sprouty was first identified in Drosophila as an antago-
nist of FGFR signaling during tracheal branching (Haco-
hen et al., 1998), and most experiments assaying the
effects of Sprouty gain-of-function in vertebrate em-
bryos have produced phenotypes consistent with roles
as FGF antagonists (Furthauer et al., 2002; Mailleux et
al., 2001; Minowada et al., 1999; Nutt et al., 2001; Perl
et al., 2003). However, genetic analysis in Drosophila
revealed that sprouty also inhibits signaling via other
RTKs (Casci et al., 1999; Kramer et al., 1999; Reich et
al., 1999), and the only Sprouty gene knockout in mice
studied thus far showed that SPRY1 inhibits the GDNF/
RET signaling pathway during kidney development
(Basson et al., 2005). In contrast, our data showing that
the Spry2 loss-of-function phenotype can be rescued
by decreasing Fgf8 gene dosage (Figure 6) indicate that
Spry2 function antagonizes FGF signaling in the oC.
Specifically, we propose that FGF8, which is produced
in the IHCs, promotes pillar cell differentiation, and
SPRY2, produced in the Deiters’ cells adjacent to the
pillar cells, antagonizes FGF8 signaling and thus pre-vents a Deiters’ cell from taking on a pillar cell fate (Fig-
ure 7B).
There is substantial evidence that FGFR3 is the re-
ceptor that transduces the FGF8 signal for pillar cell
differentiation. First, Fgfr3 is expressed in cells that
normally develop into pillar cells (Pirvola et al., 2002),
as well as in the Deiters’ cell that changes its fate in
the Spry2 null mutants (Figure 5G). Second, pillar cells
fail to develop in both Fgfr3−/− mice (Colvin et al., 1996)
and mice in which Fgf8 has been inactivated in inner
ear epithelium (U. Pirvola and A. Neubuser; B. Jacques,
M. Lewandoski, and M. Kelley, personal communica-
tion). However, we found that reducing Fgfr3 gene dos-
age had no effect on the Spry2 null phenotype in the
oC: Spry2−/−;Fgfr3+/− animals showed no rescue of
either the hearing deficit or the excess pillar cell pheno-
type (data not shown), whereas both defects were par-
tially rescued in Spry2−/−;Fgf8+/− mice. Perhaps animals
are more sensitive to Fgf8 than Fgfr3 gene dosage be-
cause FGF8 ligand may be limiting, whereas the normal
number of FGFR3 receptors may be so large that a re-
duction by roughly half still leaves sufficient numbers
of receptors available in Fgfr3 heterozygotes to func-
tion at wild-type capacity. Alternatively, other FGFRs
may function either redundantly or instead of FGFR3 to
transduce the FGF8 signal in Spry2 null Deiters’ cells.
In both Drosophila and vertebrates, Sprouty gene ex-
pression is induced by the signaling pathway that it in-
hibits (reviewed by Dikic and Giordano, 2003; Guy et
al., 2003; Kim and Bar-Sagi, 2004). In particular, Fgf8
expression has been found to be both necessary and
sufficient to induce Spry2 expression in mouse em-
bryos (Minowada et al., 1999), although it has yet to be
determined whether this is the case in the oC. However,
there is no simple relationship between FGF8 signaling
and Spry2 expression since, at P5, when Fgf8 is ex-
pressed in only the IHCs, Spry2 expression is strongest
in the Deiters’ cells, which are two and more cell diame-
ters away. If Spry2 gene expression is entirely con-
trolled by FGF8 signaling at this stage, some other
factor must ensure that Spry2 expression is downregu-
lated in the pillar cells closest to the FGF8 source.
Spry1, expressed in pillar cells, is a candidate for such
a factor.
Although SPRY2 antagonizes Fgf8 signaling, pre-
sumably via FGFR3, to prevent Deiters’ cells from un-
dergoing a fate transformation to a pillar cell, its role in
preventing the formation of excess OHCs, Deiters’
cells, and Claudius’ cells may be performed via an an-
tagonistic effect on FGFR1 signaling activated by an as
yet unknown FGF. Consistent with this hypothesis, loss
of Spry2 function and loss of Fgfr1 function in the inner
ear have opposite effects. Whereas Spry2 mutants
have excess OHCs, Fgfr1 mutants show a dramatic re-
duction in hair cell number, with OHCs preferentially af-
fected (Pirvola et al., 2002). The reduction in hair cells
observed in Fgfr1 mutants correlates with reduced cell
proliferation in the developing oC, suggesting that if
SPRY2 does antagonize FGFR1 signaling, it may func-
tion to prevent excess cell proliferation. Although the
data discussed here support the hypothesis that
SPRY2 antagonizes FGF signaling, there is as yet no
reason to think that this is the only signaling system it
Developmental Cell
562iaffects; it may antagonize other RTK signaling path-
tways in the inner ear or elsewhere during development.
d
cSpry2 Is a Mouse Deafness Locus c
What causes the hearing impairment observed in t
Spry2−/− mice? It is unlikely that the extra OHCs, Dei- o
lters’ cells, and Claudius’ cells contribute significantly
bto the observed hearing loss because extra OHC/DC
hpairs are observed at a low frequency in wild-type ani-
s
mals with presumably normal hearing (Mu et al., 1997). a
Furthermore, we found that decreasing Fgf8 gene dos- a
age in Spry2−/− mice did not rescue the extra OHC/DC W
Nphenotype, even in mice in which hearing was rescued
gto a nearly normal level. This indicates that the in-
acreased numbers of OHC/DC pairs do not prevent nor-
omal hearing.
i
Although we cannot exclude the possibility that there i
are defects in the Spry2 mutants that were missed in
our analysis, the presence of an extra pillar cell in virtu- M
ally every transverse row in the Spry2 mutants provides A
a plausible explanation for their hearing deficit. During s
Shearing, the mechanical vibrations of the middle ear os-
lsicles ultimately cause displacement of the basilar
wmembrane toward and away from the scala media. In
pthe region(s) along the length of cochlea with the
C
largest displacement, the stereocilia of the OHCs de-
flect in the excitatory direction. This results in con- B
traction of the OHCs at just the right moment so as M
to amplify the displacement of the basilar membrane A
(Ashmore, 1987; Nilsen and Russell, 1999). This amplifi- w
tcation by OHCs is essential for normal hearing, since
jPrestin knockout mice, in which OHC contraction can-
not occur, suffer from a 40–60 dB hearing loss (Liber-
Sman et al., 2002) comparable to that in Spry2 null mu-
Ctants. It is known that very little relative displacement
tof the basilar membrane occurs underneath the outer
M
pillar cell, which behaves as an inflexible strut, (
counteracting OHC contraction (Nilsen and Russell, p
1999; Olson and Mountain, 1994; Tolomeo and Holley, a
e1997). In Spry2 null mutants, the presence of an extra
pillar cell may further stiffen the cochlear partition, ne-
gating amplification by OHCs. In Fgfr3−/− mice, which I
Ialso are severely hearing impaired, the lack of pillar
fcells may render the cochlear partition too flexible, pre-
iventing optimal shear of hair cell stereocilia against the
mtectorial membrane. Tests of this model will require di- i
rect biophysical measurements of displacement of the n
basilar membrane in Spry2 and Fgfr3 null mice. A
In summary, our data show that Spry2 is required for w
bnormal hearing, and that Spry2 together with Fgfr3
Pcomprises a class of mouse deafness genes in which
Lthe primary defect appears to involve effects on sup-
o
porting rather than sensory cells in the oC. Further
studies of the dramatic and novel perturbations in the n
cytoarchitecture of oC in Spry2 null mutant mice and D
their relationship to severe hearing loss should help to (
ddetermine how supporting cells provide a cytoarchi-
ctectural scaffold whose physical properties orchestrate
(the ability of hair cells to function.
IExperimental Procedures
I
PGeneration of Spry2 Mutant Mice
tThe targeting vector used to produce the Spry2neo-flox allele in ES
cells was constructed by using w5.5 kb of Spry2 genomic DNA osolated from a BAC strain 129/Ola ES cell library (Genome Sys-
ems, St. Louis), and was electroporated into E14Tg2a.4 ES cells,
erived from the 129/Ola strain (Hooper et al., 1987). Of w70 ES
ell clones assayed by Southern blotting, four were found to be
orrectly targeted. However, a PCR analysis revealed that three of
hese clones did not contain the loxP site downstream of the Spry2
pen reading frame. Germline transmission of the Spry2neo-flox al-
ele was obtained following injection into blastocysts (performed
y the Stanford University Transgenic Research Facility) of the one
omologous recombinant ES cell line that contained both loxP
ites. Lines carrying the Spry2flox conditional and Spry2ORF null
lleles were derived by crossing mice carrying Spry2neo-flox to Flp-
nd Cre-expressing mice, as described in the legend to Figure 1.
e currently maintain the Spry2 null allele on both a mixed (FvB/
; C57/BL6; 129Sv; Swiss black) and a C57BL/6 genetic back-
round (n = 8 at present). The mutant animals described here were
ll of mixed genetic background, since most Spry2 null mutants
n the inbred background die at birth. The sequences of primers
llustrated in Figure 1 and conditions used for genotyping are given
n Table S3.
easurement of Hearing
BR tests were conducted as described (Jero et al., 2001). Click
timuli were decreased in 5 dB steps, from 90-0 or 70-0 dB peak
PL. Threshold was identified as the midpoint between the stimu-
us intensity that produced a replicable waveform and at which the
aveform could not be reproducibly detected. All procedures were
erformed in accordance with the regulations of the UCSF Animal
are Committee.
one and Cartilage Stain and Paint Filling
iddle ear bones were prepared and stained with Alcian blue and
lizarin red according to standard protocols. Paint-fill injections
ere performed as described (Martin and Swanson, 1993), except
hat a 1% solution of Correction Fluid in methyl salicylate was in-
ected instead of paint.
canning Electron Microscopy
ochlea from three Spry2−/− mice and two Spry2+/+ littermate con-
rols were dissected on P21 and fixed in 2.5% glutaraldehyde, 0.1
phospate buffer. The osmium tetroxide-thiocarbohydrazide
OTOTO) procedure was used to stain the cochlea prior to critical
oint drying and sputter coating with gold as described in Self et
l., 1998. Specimens were examined on a Hitachi S-5000 field
mission microscope.
mmunohistochemistry
nner ears were dissected in phosphate-buffered saline (PBS) and
ixed overnight in 4% paraformaldehyde (PFA). After embedding
n 4% agarose, 100 m vibratome sections were cut through the
odiolus of the cochlea to expose the oC. Sections were blocked
n PBTN (PBS, 1% bovine serum albumin, 0.1% Triton X-100, 5%
ormal goat serum) and incubated in primary antibody overnight.
fter washing in PBT (PBS, 1% BSA, 0.1% Triton X-100), sections
ere incubated overnight with the appropriate fluorescently la-
eled secondary antibody (Jackson ImmunoResearch) diluted in
BTN, then washed in PBT prior to mounting in Vectashield (Vector
aboratories). Samples were examined on either a Leica TCS NT
r a BioRad 1024 MP confocal microscope.
Primary antibodies at the dilutions indicated were against: p75
erve growth factor receptor (Chemicon, 1:1000); α-tubulin (clone
M1A, Sigma, 1:500); S100 (DakoCytomation, 1:200); neurofilament
clone 2H3, Developmental Studies Hybridoma Bank, 1:200). Rho-
amine phalloidin (Molecular Probes) was used at 1:50 dilution. Nu-
lei were counterstained with TO-PRO-3 (far red) or YO-PRO-1
green) (Molecular Probes).
n Situ Hybridization
nner ears dissected from CD1 embryos or pups were fixed in 4%
FA, embedded in OCT, and cryo-sectioned through the modiolus
o cross-section the oC. RNA in situ hybridization was performed
n cryo-sectioned tissue as described on the Dr. Alexandra Joyner
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563lab website by using mouse probes for Spry2, Spry1, Fgf8, and
Fgfr3.
Pillar Cell Quantification
Inner ears fixed in 4% PFA were decalcified in 10% EDTA, samples
were embedded in 4% agarose, and 100 m vibratome sections
were cut in the transverse plane through the entire cochlea. Sec-
tions were processed for S100 staining and examined by confocal
microscopy as described above. For each oC in which pillar cells
could be clearly visualized, a z-stack was compiled with a total
thickness of 50 m and a step size of 2.5 m or smaller. Pillar cell
and hair cell numbers were determined from each 50 m stack.
Multiple 50 m samplings, scattered along the length of the co-
chlea, were measured. For each cochlea, between 300 and 450 m
of total distance along its length was examined.
Supplemental Data
Supplemental Data showing hair and pillar cell quantification, ABR
wave i and wave ii peak amplitudes, PCR primer information, and
histological sections are available at http://www.developmentalcell.
com/cgi/content/full/8/4/553/DC1/.
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